Clinical Trials Browser

Phase 1/2 × belinostat × Other hematologic neoplasm × Clear all

NCT00878722 2015-07-28

Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy

Phase 1/2 Completed

41 enrolled 22 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute